These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 18315419)

  • 1. Predictability of clinical outcomes following regenerative therapy in intrabony defects.
    Aichelmann-Reidy ME; Reynolds MA
    J Periodontol; 2008 Mar; 79(3):387-93. PubMed ID: 18315419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Five-year results of a prospective, randomized, controlled study evaluating treatment of intra-bony defects with a natural bone mineral and GTR.
    Sculean A; Schwarz F; Chiantella GC; Donos N; Arweiler NB; Brecx M; Becker J
    J Clin Periodontol; 2007 Jan; 34(1):72-7. PubMed ID: 17243997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of intrabony defects by different surgical procedures. A literature review.
    Laurell L; Gottlow J; Zybutz M; Persson R
    J Periodontol; 1998 Mar; 69(3):303-13. PubMed ID: 9579616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autogenous periosteal barrier membranes and bone grafts in the treatment of periodontal intrabony defects of single-rooted teeth: a 12-month reentry randomized controlled clinical trial.
    Paolantonio M; Femminella B; Coppolino E; Sammartino G; D'Arcangelo C; Perfetti G; Perinetti G
    J Periodontol; 2010 Nov; 81(11):1587-95. PubMed ID: 20583915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgical treatment of periodontal intrabony defects with calcium sulfate implant and barrier versus collagen barrier or open flap debridement alone: a 12-month randomized controlled clinical trial.
    Paolantonio M; Perinetti G; Dolci M; Perfetti G; Tetè S; Sammartino G; Femminella B; Graziani F
    J Periodontol; 2008 Oct; 79(10):1886-93. PubMed ID: 18834243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of platelet-rich plasma, bovine porous bone mineral, and guided tissue regeneration versus platelet-rich plasma and bovine porous bone mineral in the treatment of intrabony defects: a reentry study.
    Lekovic V; Camargo PM; Weinlaender M; Vasilic N; Kenney EB
    J Periodontol; 2002 Feb; 73(2):198-205. PubMed ID: 11895286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical evaluation of a biphasic calcium composite grafting material in the treatment of human periodontal intrabony defects: a 12-month randomized controlled clinical trial.
    Stein JM; Fickl S; Yekta SS; Hoischen U; Ocklenburg C; Smeets R
    J Periodontol; 2009 Nov; 80(11):1774-82. PubMed ID: 19905932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of bovine-derived anorganic bone associated with guided tissue regeneration in intrabony defects. Six-month evaluation at re-entry.
    Batista EL; Novaes AB; Simonpietri JJ; Batista FC
    J Periodontol; 1999 Sep; 70(9):1000-7. PubMed ID: 10505802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of platelet-rich plasma on the healing of intrabony defects treated with an anorganic bovine bone mineral and expanded polytetrafluoroethylene membranes.
    Döri F; Huszár T; Nikolidakis D; Arweiler NB; Gera I; Sculean A
    J Periodontol; 2007 Jun; 78(6):983-90. PubMed ID: 17539709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Five-year clinical results for treatment of intrabony defects with EMD, guided tissue regeneration and open-flap debridement: a case series.
    Mitani A; Takasu H; Horibe T; Furuta H; Nagasaka T; Aino M; Fukuda M; Fujimura T; Mogi M; Noguchi T
    J Periodontal Res; 2015 Feb; 50(1):123-30. PubMed ID: 24815103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of platelet-rich plasma on the healing of intrabony defects treated with Beta tricalcium phosphate and expanded polytetrafluoroethylene membranes.
    Döri F; Huszár T; Nikolidakis D; Tihanyi D; Horváth A; Arweiler NB; Gera I; Sculean A
    J Periodontol; 2008 Apr; 79(4):660-9. PubMed ID: 18380559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative study utilizing open flap debridement with and without enamel matrix derivative in the treatment of periodontal intrabony defects: a 12-month re-entry study.
    Froum SJ; Weinberg MA; Rosenberg E; Tarnow D
    J Periodontol; 2001 Jan; 72(1):25-34. PubMed ID: 11210070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors influencing treatment outcomes in mandibular Class II furcation defects.
    Tsao YP; Neiva R; Al-Shammari K; Oh TJ; Wang HL
    J Periodontol; 2006 Apr; 77(4):641-6. PubMed ID: 16584345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generalizability of the added benefits of guided tissue regeneration in the treatment of deep intrabony defects. Evaluation in a multi-center randomized controlled clinical trial.
    Tonetti MS; Cortellini P; Suvan JE; Adriaens P; Baldi C; Dubravec D; Fonzar A; Fourmousis I; Magnani C; Muller-Campanile V; Patroni S; Sanz M; Vangsted T; Zabalegui I; Pini Prato G; Lang NP
    J Periodontol; 1998 Nov; 69(11):1183-92. PubMed ID: 9848527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A surgical reentry study on the influence of platelet-rich plasma in enhancing the regenerative effects of bovine porous bone mineral and guided tissue regeneration in the treatment of intrabony defects in humans.
    Camargo PM; Lekovic V; Weinlaender M; Divnic-Resnik T; Pavlovic M; Kenney EB
    J Periodontol; 2009 Jun; 80(6):915-23. PubMed ID: 19485821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of platelet-rich plasma on the healing of intrabony defects treated with an anorganic bovine bone mineral: a pilot study.
    Döri F; Kovács V; Arweiler NB; Huszár T; Gera I; Nikolidakis D; Sculean A
    J Periodontol; 2009 Oct; 80(10):1599-605. PubMed ID: 19792848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical outcomes following treatment of human intrabony defects with GTR/bone replacement material or access flap alone. A multicenter randomized controlled clinical trial.
    Tonetti MS; Cortellini P; Lang NP; Suvan JE; Adriaens P; Dubravec D; Fonzar A; Fourmousis I; Rasperini G; Rossi R; Silvestri M; Topoll H; Wallkamm B; Zybutz M
    J Clin Periodontol; 2004 Sep; 31(9):770-6. PubMed ID: 15312100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy of bone replacement grafts in the treatment of periodontal osseous defects. A systematic review.
    Reynolds MA; Aichelmann-Reidy ME; Branch-Mays GL; Gunsolley JC
    Ann Periodontol; 2003 Dec; 8(1):227-65. PubMed ID: 14971256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An evaluation of bioactive glass in the treatment of periodontal defects: a meta-analysis of randomized controlled clinical trials.
    Sohrabi K; Saraiya V; Laage TA; Harris M; Blieden M; Karimbux N
    J Periodontol; 2012 Apr; 83(4):453-64. PubMed ID: 21861641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical outcomes after treatment of non-contained intrabony defects with enamel matrix derivative or guided tissue regeneration: a 12-month randomized controlled clinical trial.
    Siciliano VI; Andreuccetti G; Siciliano AI; Blasi A; Sculean A; Salvi GE
    J Periodontol; 2011 Jan; 82(1):62-71. PubMed ID: 20809859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.